Opus Genetics, Inc. (IRD) Net margin 2019–2025
Opus Genetics, Inc. (IRD) net profit margin by fiscal year — reported net income divided by reported revenue.
-349.3%FY2025 · since FY2019: -205.6% → -349.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -349.3% | +174.1 pp |
| FY2024 | -523.4% | -471.0 pp |
| FY2023 | -52.4% | -97.3 pp |
| FY2022 | 44.9% | +9670.2 pp |
| FY2021 | -9625.3% | — |
| FY2019 | -205.6% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice